Lv14
20 积分 2022-05-29 加入
Recombinant antibody fragment therapeutics: Current status and future prospects of scFv, nanobody, and mimotopes
9小时前
待确认
A structure and knowledge-based combinatorial approach to engineering universal scFv antibodies against influenza M2 protein
1天前
已完结
Structure‐based engineering of an antiangiogenic scFv antibody for soluble production in E. coli without loss of activity
1天前
已完结
AI models for protein design are driving antibody engineering
2天前
已完结
Rigid linker peptides improve the stability and anti‐inflammation effect of human serum albumin and α‐melanocyte‐stimulating hormone fusion proteins
3天前
已完结
Immunoglobulin M perception by FcμR
3天前
已完结
Structural basis for Fc receptor recognition of immunoglobulin M
3天前
已完结
Emicizumab as first line therapy in acquired hemophilia A
9天前
已完结
Exploration of peptides bound to MHC class I molecules in melanoma
1个月前
已完结
Exploration of peptides bound to MHC class I molecules in melanoma
1个月前
已完结
皖公网安备34019202002308
